Genipin-crosslinked fibrin seeded with oxidized alginate microbeads as a novel composite biomaterial strategy for intervertebral disc cell therapy
Source abstract
Abstract
Discectomy procedures alleviate disability caused by intervertebral disc (IVD) herniation, but do not repair herniation-induced annulus fibrosus (AF) defects. Cell therapy shows promise for IVD repair, yet cell delivery biomaterials capable of sealing AF defects and restoring biomechanical function have poor biological performance. To balance the biomechanical and biological demands of IVD cell delivery biomaterials, we engineered an injectable composite biomaterial using cell-laden, degradable oxidized alginate (OxAlg) microbeads (MBs) to deliver AF cells within high-modulus genipin-crosslinked fibrin (FibGen) hydrogels (FibGen + MB composites). Conceptually, the high-modulus FibGen would immediately stabilize injured IVDs, while OxAlg MBs would protect and release cells required for long-term healing. We first showed that AF cells microencapsulated in OxAlg MBs maintained high viability and, upon release, displayed phenotypic AF cell morphology and gene expression. Next, we created cell-laden FibGen + MB composites and demonstrated that OxAlg MBs functionalized with RGD peptides (MB-RGD) minimized AF cell apoptosis and retained phenotypic gene expression. Further, we showed that cell-laden FibGen + MB composites are biomechanically stable and promote extracellular matrix (ECM) synthesis in long-term in vitro culture. Lastly, we evaluated cell-laden FibGen + MB-RGD composites in a long-term bovine caudal IVD organ culture bioreactor and found that composites had low herniation risk, provided superior biomechanical and biological repair to discectomy controls, and retained anabolic cells within the IVD injury space. This novel injectable composite hydrogel strategy shows promise as an IVD cell delivery sealant with potentially broad applications for its capacity to balance biomechanical and biological performance.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Spine and Intervertebral Disc Pathology · Musculoskeletal pain and rehabilitation · Pain Management and Opioid Use
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. US Health care spending by payer and Health condition10.1001/jama.2020.0734 ↗
2. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 201510.1016/S0140-6736(16)31678-6 ↗
3. What low back pain is and why we need to pay attention10.1016/S0140-6736(18)30480-X ↗
4. Pathomechanisms of discogenic low back pain in humans and animal models10.1016/j.spinee.2013.07.490 ↗
5. Prospective multiple outcomes study of outpatient lumbar microdiscectomy: should 75 to 80% success rates be the norm?
6. Population-based trends in volumes and rates of ambulatory lumbar spine surgery10.1097/01.brs.0000229148.63418.c1 ↗
7. Surgical versus nonoperative treatment for lumbar disc herniation: four-year results for the Spine Patient Outcomes Research Trial (SPORT)10.1097/BRS.0b013e31818ed8f4 ↗
8. Surgical versus nonoperative treatment for lumbar disc herniation: eight-year results for the spine patient outcomes research trial10.1097/BRS.0000000000000088 ↗
9. Clinical outcomes after lumbar discectomy for sciatica: the effects of fragment type and anular competence10.2106/00004623-200301000-00016 ↗
10. A prospective cohort study of close interval computed tomography and magnetic resonance imaging after primary lumbar discectomy: factors associated with recurrent disc herniation and disc height loss10.1097/BRS.0b013e3181b34a9a ↗
11. An evidence-based review of the literature on the consequences of conservative versus aggressive discectomy for the treatment of primary disc herniation with radiculopathy10.1016/j.spinee.2008.08.005 ↗
12. Reoperation for recurrent intervertebral disc herniation in the spine patient outcomes research trial: analysis of rate, risk factors, and outcome10.1097/BRS.0000000000002088 ↗
13. Role of biomechanics in intervertebral disc degeneration and regenerative therapies: what needs repairing in the disc and what are promising biomaterials for its repair?10.1016/j.spinee.2012.12.002 ↗
14. Anular Repair Clinical Study Group. Prospective, multicenter, randomized, controlled study of anular repair in lumbar discectomy: two-year follow-up10.1097/BRS.0b013e31828b2e2f ↗
15. Effect of an annular closure device (Barricaid) on same-level recurrent disk herniation and disk height loss after primary lumbar discectomy: two-year results of a multicenter prospective cohort study10.1097/BSD.0b013e3182956ec5 ↗
16. Annular closure device lowers reoperation risk 4 years after lumbar discectomy
17. Risk factors for early reherniation after lumbar discectomy with or without annular closure: results of a multicenter randomized controlled study10.1007/s00701-020-04505-4 ↗
18. 2021
19. Stem cell therapy for intervertebral disc regeneration: obstacles and solutions10.1038/nrrheum.2015.13 ↗
20. Biomaterials for intervertebral disc regeneration and repair10.1016/j.biomaterials.2017.03.013 ↗
21. To serve and protect: hydrogels to improve stem cell-based therapies10.1016/j.stem.2015.12.004 ↗
22. Mesenchymal stem cells injection in degenerated intervertebral disc: cell leakage may induce osteophyte formation10.1002/term.433 ↗
23. Balancing biological and biomechanical performance in intervertebral disc repair: a systematic review of injectable cell delivery biomaterials10.22203/eCM.v040a15 ↗
24. Cell therapy for intervertebral disc repair: advancing cell therapy from bench to clinics10.22203/eCM.v027sa02 ↗
25. Design requirements for annulus fibrosus repair: review of forces, displacements, and material properties of the intervertebral disk and a summary of candidate hydrogels for repair10.1115/1.4032353 ↗
26. Biphasic scaffold for annulus fibrosus tissue regeneration10.1016/j.biomaterials.2007.10.031 ↗
27. Injectable, high-density collagen gels for annulus fibrosus repair: an in vitro rat tail model10.1002/jbm.a.35388 ↗
28. In vitro characterization and in vivo behavior of human nucleus pulposus and annulus fibrosus cells in clinical-grade fibrin and collagen-enriched fibrin gels10.1089/ten.tea.2014.0279 ↗
29. Photocrosslinkable laminin-functionalized polyethylene glycol hydrogel for intervertebral disc regeneration10.1016/j.actbio.2013.11.013 ↗
30. Injectable thermoreversible hyaluronan-based hydrogels for nucleus pulposus cell encapsulation10.1007/s00586-011-1976-2 ↗
31. Lower crosslinking density enhances functional nucleus pulposus-like matrix elaboration by human mesenchymal stem cells in carboxymethylcellulose hydrogels10.1002/jbm.a.35552 ↗
32. Duration of TGF-β3 exposure impacts the chondrogenic maturation of human MSCs in photocrosslinked carboxymethylcellulose hydrogels10.1007/s10439-014-1179-1 ↗
33. Cell-seeded adhesive biomaterial for repair of annulus fibrosus defects in intervertebral discs10.1089/ten.tea.2017.0334 ↗
34. Genipin-cross-linked type II collagen scaffold promotes the differentiation of adipose-derived stem cells into nucleus pulposus-like cells10.1002/jbm.a.36325 ↗
35. Modulation of mesenchymal stem cell chondrogenesis in a tunable hyaluronic acid hydrogel microenvironment10.1016/j.biomaterials.2012.01.065 ↗
36. Type II collagen-hyaluronan hydrogel--a step towards a scaffold for intervertebral disc tissue engineering10.22203/eCM.v020a12 ↗
37. Genipin cross-linked type II collagen/chondroitin sulfate composite hydrogel-like cell delivery system induces differentiation of adipose-derived stem cells and regenerates degenerated nucleus pulposus10.1016/j.actbio.2018.03.019 ↗
38. Silk-fibrin/hyaluronic acid composite gels for nucleus pulposus tissue regeneration10.1089/ten.tea.2010.0747 ↗
39. Nanocellulose reinforced gellan-gum hydrogels as potential biological substitutes for annulus fibrosus tissue regeneration10.1016/j.nano.2017.11.011 ↗
40. Lessons to be learned and future directions for intervertebral disc biomaterials10.1016/j.actbio.2018.08.004 ↗
41. Boosting tendon repair: interplay of cells, growth factors and scaffold-free and gel-based carriers10.1186/s40634-017-0117-1 ↗
42. Natural polymers for the microencapsulation of cells10.1098/rsif.2014.0817 ↗
43. Cell microencapsulation with synthetic polymers10.1002/jbm.a.35205 ↗
44. Umbilical cord stem cells released from alginate-fibrin microbeads inside macroporous and biofunctionalized calcium phosphate cement for bone regeneration10.1016/j.actbio.2012.02.021 ↗
45. Human umbilical cord stem cell encapsulation in novel macroporous and injectable fibrin for muscle tissue engineering10.1016/j.actbio.2012.08.009 ↗
46. Human embryonic stem cell encapsulation in alginate microbeads in macroporous calcium phosphate cement for bone tissue engineering10.1016/j.actbio.2012.05.016 ↗
47. Macroporous hydrogel scaffolds for three-dimensional cell culture and tissue engineering10.1089/ten.teb.2016.0465 ↗
48. Potential use of alginate beads as a chondrocyte delivery vehicle and stepwise dissolving porogen in a hydrogel scaffold for cartilage tissue engineering10.1039/C5RA15376J ↗
49. A temperature-cured dissolvable gelatin microsphere-based cell carrier for chondrocyte delivery in a hydrogel scaffolding system10.1016/j.actbio.2012.10.047 ↗
50. Fibrin-genipin adhesive hydrogel for annulus fibrosus repair: performance evaluation with large animal organ culture, in situ biomechanics, and in vivo degradation tests10.22203/eCM.v028a03 ↗
51. Characterization of mechanics and cytocompatibility of fibrin-genipin annulus fibrosus sealant with the addition of cell adhesion molecules10.1089/ten.tea.2012.0714 ↗
52. Genipin-crosslinked fibrin hydrogels as a potential adhesive to augment intervertebral disc annulus repair10.22203/eCM.v021a28 ↗
53. Crosslinker concentration controls TGFβ-3 release and annulus fibrosus cell apoptosis in genipin-crosslinked fibrin hydrogels10.22203/eCM.v039a14 ↗
54. Genipin-enhanced fibrin hydrogel and novel silk for intervertebral disc repair in a loaded bovine organ culture model10.3390/jfb9030040 ↗
55. 1982
56. Oxidized alginate-based hydrogels for tissue engineering applications: a review10.1021/acs.biomac.7b01331 ↗
57. Degradation of partially oxidized alginate and its potential application for tissue engineering10.1021/bp010070p ↗
58. Value and limitations of using the bovine tail as a model for the human lumbar spine10.1097/01.brs.0000147744.74215.b0 ↗
59. Are animal models useful for studying human disc disorders/degeneration?10.1007/s00586-007-0414-y ↗
60. Single-cell RNA-sequencing atlas of bovine caudal intervertebral discs: discovery of heterogeneous cell populations with distinct roles in homeostasis10.1096/fj.202101149R ↗
61. Development and validation of a bioreactor system for dynamic loading and mechanical characterization of whole human intervertebral discs in organ culture10.1016/j.jbiomech.2014.03.015 ↗
62. The fast release of stem cells from alginate-fibrin microbeads in injectable scaffolds for bone tissue engineering10.1016/j.biomaterials.2011.06.045 ↗
63. Chemical evaluation of conformational differences in native and chemically modified proteins10.1016/0304-4165(66)90442-9 ↗
64. Cartilage regeneration using biodegradable oxidized alginate/hyaluronate hydrogels
65. An injectable calcium phosphate-alginate hydrogel-umbilical cord mesenchymal stem cell paste for bone tissue engineering10.1016/j.biomaterials.2010.05.017 ↗
66. Engineering bone regeneration with novel cell-laden hydrogel microfiber-injectable calcium phosphate scaffold10.1016/j.msec.2017.02.158 ↗
67. Transcriptional profiling distinguishes inner and outer annulus fibrosus from nucleus pulposus in the bovine intervertebral disc10.1007/s00586-017-5150-3 ↗
68. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method10.1006/meth.2001.1262 ↗
69. Frequency-dependent behavior of the intervertebral disc in response to each of six degree of freedom dynamic loading: solid phase and fluid phase contributions10.1097/BRS.0b013e31817bb116 ↗
70. A comprehensive tool box for large animal studies of intervertebral disc degeneration10.1002/jsp2.1162 ↗
71. Swanson · 1997
72. Treatment of lumbar disc herniation: evidence-based practice
73. 2017 · vol. 1479
74. Shear reversible cell/microsphere aggregate as an injectable for tissue regeneration10.1002/mabi.201300365 ↗
75. Alginate/laponite hydrogel microspheres co-encapsulating dental pulp stem cells and VEGF for endodontic regeneration10.1016/j.actbio.2020.07.012 ↗
76. Influence of key processing parameters and seeding density effects of microencapsulated chondrocytes fabricated using electrohydrodynamic spraying10.1088/1758-5090/aacb95 ↗
77. Cell encapsulation via microtechnologies10.1016/j.biomaterials.2013.12.073 ↗
78. Bio-electrospraying: a potentially safe technique for delivering progenitor cells10.1002/bit.22734 ↗
79. Initial characterization of the metabolism of intervertebral disc cells encapsulated in microspheres10.1002/jor.1100100510 ↗
80. Control of adhesive ligand density for modulation of nucleus pulposus cell phenotype10.1016/j.biomaterials.2020.120057 ↗
81. Bioactive in situ crosslinkable polymer-peptide hydrogel for cell delivery to the intervertebral disc in a rat model10.1016/j.actbio.2021.06.045 ↗
82. Integrins and anoikis10.1016/S0955-0674(97)80124-X ↗
83. Mechanism and kinetics of the crosslinking reaction between biopolymers containing primary amine groups and genipin10.1002/pola.10960 ↗
84. Chemical crosslinking of biopolymeric scaffolds: current knowledge and future directions of crosslinked engineered bone scaffolds10.1016/j.ijbiomac.2017.08.184 ↗
85. Fibrin: a versatile scaffold for tissue engineering applications10.1089/ten.teb.2007.0435 ↗
86. Matrix elasticity of void-forming hydrogels controls transplanted-stem-cell-mediated bone formation10.1038/nmat4407 ↗
87. Sacrificial nanofibrous composites provide instruction without impediment and enable functional tissue formation10.1073/pnas.1206962109 ↗
88. Organ culture bioreactors--platforms to study human intervertebral disc degeneration and regenerative therapy10.2174/1574888X10666150312102948 ↗
89. Ethical use of animal models in musculoskeletal research10.1002/jor.23485 ↗
90. Russell and Burch's 3Rs then and now: the need for clarity in definition and purpose
91. Review of in vitro mechanical testing for intervertebral disc injectable biomaterials10.1016/j.jmbbm.2021.104703 ↗
92. Needle puncture injury causes acute and long-term mechanical deficiency in a mouse model of intervertebral disc degeneration10.1002/jor.22355 ↗
93. Longitudinal characterization of intervertebral disc remodeling following acute annular injury in a rat model of degenerative disc disease10.1080/03008207.2019.1635589 ↗
94. Disc degeneration in the rabbit: a biochemical and radiological comparison between four disc injury models10.1097/01.brs.0000149191.02304.9b ↗
95. A bovine nucleus pulposus explant culture model
96. Intervertebral disc regeneration: from cell therapy to the development of novel bioinspired endogenous repair strategies10.1016/j.addr.2018.04.017 ↗
97. Shapiro · 2014
98. Aberrant mechanosensing in injured intervertebral discs as a result of boundary-constraint disruption and residual-strain loss10.1038/s41551-019-0458-4 ↗
99. Extracellular vesicles as an emerging treatment option for intervertebral disc degeneration: therapeutic potential, translational pathways, and regulatory considerations10.1002/adhm.202100596 ↗
100. Morphological and biomechanical effects of annulus fibrosus injury and repair in an ovine cervical model10.1002/jsp2.1074 ↗